<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Senescence, an inherent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressive mechanism, is a critical determinant for chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we show that the monocarboxylate transporter 2 (MCT2) protein was <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-selectively expressed in human colorectal <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and knockdown of MCT2 induces <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction, cell-cycle arrest, and senescence without additional cellular stress in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover, the reactive oxygen species (ROS) scavenger, <z:chebi fb="0" ids="28939">N-acetylcysteine</z:chebi>, blocked MCT2 knockdown-induced <z:mpath ids='MPATH_73'>growth arrest</z:mpath> and cellular senescence, indicating a pivotal role of ROS in this pathway </plain></SENT>
<SENT sid="3" pm="."><plain>Dramatic induction of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="1" ids="18421">superoxide</z:chebi> generation and decrease in ATP production was observed, indicating that <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction is the major mechanism underlying MCT2 knockdown-induced ROS generation </plain></SENT>
<SENT sid="4" pm="."><plain>Senescence-associated DNA damage was also evident from the increase in promyelocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> bodies, Î³H2AX foci, and SAHF </plain></SENT>
<SENT sid="5" pm="."><plain>Conversely, overexpression of MCT2 prevented <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>-induced ROS accumulation (P = 0.0002) and cell growth inhibition (P = 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>MCT2 knockdown suppressed KRAS mutant <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> growth in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, MCT2 knockdown and <z:chebi fb="0" ids="35610">cytostatic</z:chebi> drug combination further enhanced the antitumor effect </plain></SENT>
<SENT sid="8" pm="."><plain>These findings support the use of MCT2 as a promising target for inhibition of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>